PD-L2 is a second ligand for PD-1 and inhibits T cell activation
2001 · Nature Immunology · 2,923 citations
https://doi.org/10.1038/85330
B
Beatriz M. Carreno
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
146
Papers
20.3K
Citations
45
h-index
71
i10-index
Beatriz M. Carreno is an academic researcher from California University of Pennsylvania. The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune Cell Function and Interaction & T-cell and B-cell Immunology. The author has an h-index of 45, co-authored 125 publications.
ORCID: 0000-0002-8123-2035Papers by this author
worksCRISPR-engineered T cells in patients with refractory cancer
2020 · Science · 1,396 citations
https://doi.org/10.1126/science.aba7365
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
2016 · Genome Medicine · 499 citations
https://doi.org/10.1186/s13073-016-0264-5
TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man
1995 · The Journal of Immunology · 114 citations
https://doi.org/10.4049/jimmunol.155.10.4726
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
2021 · Nature Communications · 108 citations
https://doi.org/10.1038/s41467-021-24562-2
The Inhibitory Function of CTLA-4 Does Not Require Its Tyrosine Phosphorylation
2000 · The Journal of Immunology · 79 citations
https://doi.org/10.4049/jimmunol.164.1.49
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat